Literature DB >> 8947606

The effect of age on the transendothelial migration of human T lymphocytes.

P Stohlawetz1, T Kolussi, S Jahandideh-Kazempour, S Kudlacek, W Graninger, R Willvonseder, P Pietschmann.   

Abstract

Since the migration of immunologically active cells into perivascular tissue is an important step in acute and chronic inflammation, the authors studied the possible influence of age on the transendothelial migration of T cells in an in vitro model. After incubation on collagen gels coated with human endothelial cells, three populations of T cells of elderly and young subjects were harvested: non-adherent (NAD), bound (BND) and migrated (MIG) cells. The percentages of the BND and MIG fractions were similar in the young and elderly groups. Phenotypic analysis showed that in the starting population of the elderly subjects T-cell subpopulations that have an increased capacity of transendothelial migration (e.g., CD4+ memory cells, CD8+/CD57+ cells) were enriched: nevertheless ageing was not associated with an increase in the transendothelial migration of T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947606     DOI: 10.1046/j.1365-3083.1996.d01-331.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

Review 1.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Impairment of non-muscle myosin IIA in human CD4+ T cells contributes to functional deficits in the elderly.

Authors:  Stefania Cane; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Cell Mol Immunol       Date:  2011-10-10       Impact factor: 11.530

3.  Altered regulation of CXCR4 expression during aging contributes to increased CXCL12-dependent chemotactic migration of CD4(+) T cells.

Authors:  Stefania Cané; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.